Imperva, Inc. engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments. Its SecureSphere product also secures business-critical applications and data; and provides an accelerated route to address regulatory compliance and establishes a repeatable process for data risk management. The company's Incapsula service delivers cloud-based Website security, distributed denial of service protection, and load balancing and failover; and is designed to deploy and accessible to businesses that need to optimize the security, speed, and availability of their Websites. Its products also include ThreatRadar that provides reputation and crowdsourced security intelligence services; CounterBreach, which protects enterprise data from theft and loss due to compromised, malicious, and careless users; and Imperva Camouflage Data Masking that creates functional data for development, testing, and training by disguising sensitive information while maintaining the characteristics of the original data. In addition, the company provides ongoing product support services for hardware and software; and professional and training services. Imperva, Inc. offers its products and services to banks, retailers, insurers, technology and telecommunication companies, and hospitals; and the United States and other national, state, and local government agencies through a network of distributors and resellers. The company was founded in 2002 and is headquartered in Redwood Shores, California.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Prepackaged software
Sub-IndustrySystems Software
SectorComputer and Technology
Current SymbolNASDAQ:IMPV
Previous Symbol
CUSIP45321L10
Phone650-345-9000
Debt
Debt-to-Equity RatioN/A
Current Ratio2.04
Quick Ratio2.04
Price-To-Earnings
Trailing P/E Ratio-199.43
Forward P/E Ratio-52.78
P/E GrowthN/A
Sales & Book Value
Annual Sales$321.72 million
Price / Sales6.12
Cash Flow$0.0559 per share
Price / Cash1,001.46
Book Value$9.26 per share
Price / Book6.04
Profitability
EPS (Most Recent Fiscal Year)($0.28)
Net Income$22.86 million
Net Margins-8.00%
Return on Equity-5.62%
Return on Assets-3.29%
Miscellaneous
Employees1,020
Outstanding Shares35,200,000
Market Cap$1.97 billion
OptionableOptionable
Imperva (NASDAQ:IMPV) Frequently Asked Questions
What is Imperva's stock symbol?
Imperva trades on the NASDAQ under the ticker symbol "IMPV."
How were Imperva's earnings last quarter?
Imperva Inc (NASDAQ:IMPV) announced its earnings results on Wednesday, October, 31st. The software maker reported $0.43 earnings per share for the quarter, beating analysts' consensus estimates of $0.18 by $0.25. The software maker earned $91.63 million during the quarter, compared to analyst estimates of $89.24 million. Imperva had a negative net margin of 8.00% and a negative return on equity of 5.62%. View Imperva's Earnings History.
When is Imperva's next earnings date?
What guidance has Imperva issued on next quarter's earnings?
Imperva updated its third quarter 2018 earnings guidance on Wednesday, October, 10th. The company provided EPS guidance of $0.20-0.25 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.14. The company issued revenue guidance of $90-92 million, compared to the consensus revenue estimate of $87.97 million.
What price target have analysts set for IMPV?
14 brokers have issued 12-month target prices for Imperva's shares. Their forecasts range from $48.00 to $70.00. On average, they expect Imperva's stock price to reach $55.8958 in the next year. This suggests a possible upside of 0.1% from the stock's current price. View Analyst Price Targets for Imperva.
What is the consensus analysts' recommendation for Imperva?
14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Imperva in the last year. There are currently 10 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Imperva.
What are Wall Street analysts saying about Imperva stock?
Here are some recent quotes from research analysts about Imperva stock:
- 1. According to Zacks Investment Research, "Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company's SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. " (10/12/2018)
- 2. Evercore ISI analysts commented, "We believe most strategic acquirers, however, have been less active in the space. Recall that in October 2016, IMPV was forecasted to grow revenue low double digits with just about breakeven non-GAAP profitability. The company finished 2017 with 22% revenue growth and ~11% operating margins. Forecasts for F18 revenue have previously been cut due to a shift to more ratable sales (see our prior earnings note here). The uncertainty around growth (better measured by billings) and profitability caused the more recent decline in the stock, but we believe the fundamentals are in a materially better position than during the October 2016 timeframe. Given the announced acquisition, we are downgrading IMPV from and moving our PT from $56 to $55.75." (10/11/2018)
- 3. BTIG Research analysts commented, "Imperva posted a strong beat on Non-GAAP EPS, a moderate beat on revenues, and weaker than expected billings, deferred revenues, operating margin and cash flows. Disruptions in the North American salesforce during the quarter seems to have created challenges in delivering the results. While Asia Pacific seems to have been off to a strong start, with Europe following, without the North America engine in full throttle, Imperva cannot get to its destination. We like management’s vision to transform into a hybrid cybersecurity leader, but until we see tangible outcomes, we are forced to remain on the sidelines. Maintain Neutral." (4/29/2018)
Has Imperva been receiving favorable news coverage?
News headlines about IMPV stock have trended somewhat positive on Tuesday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Imperva earned a daily sentiment score of 0.9 on InfoTrie's scale. They also gave headlines about the software maker a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next few days.
Who are some of Imperva's key competitors?
Some companies that are related to Imperva include Atlassian (TEAM), Nutanix (NTNX), Paycom Software (PAYC), Black Knight (BKI), Tyler Technologies (TYL), Micro Focus International (MFGP), Guidewire Software (GWRE), Docusign (DOCU), National Instruments (NATI), Momo (MOMO), Okta (OKTA), Konami (KNMCY), Ceridian HCM (CDAY), HubSpot (HUBS) and New Relic (NEWR).
Who are Imperva's key executives?
Imperva's management team includes the folowing people:
- Mr. Christopher S. Hylen, Pres, CEO & Director (Age 57)
- Ms. Trâm T. Phi, Chief Legal Officer & Chief of Staff (Age 47)
- Mr. Michael J. Burns, Chief Financial Officer & Treasurer (Age 52)
- Mr. Aharon Strosberg, VP of Operations
- Mr. Terry Ray, Chief Technology Officer
Who are Imperva's major shareholders?
Imperva's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.86%), Pictet Asset Management Ltd. (1.94%), Rothschild & Co. Asset Management US Inc. (1.66%), Emerald Advisers Inc. PA (1.48%), Credit Suisse AG (1.36%) and Emerald Mutual Fund Advisers Trust (1.35%). Company insiders that own Imperva stock include Amichai Shulman, Anthony J Bettencourt, Mark E Kraynak, Michael D Mooney, Sunil D Nagdev and Terrence J Schmid. View Institutional Ownership Trends for Imperva.
Which institutional investors are selling Imperva stock?
IMPV stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Wells Fargo & Company MN, Hsbc Holdings PLC, Elk Creek Partners LLC, Rothschild & Co. Asset Management US Inc., Stanley Laman Group Ltd., Russell Investments Group Ltd. and Cambiar Investors LLC. Company insiders that have sold Imperva company stock in the last year include Anthony J Bettencourt and Michael D Mooney. View Insider Buying and Selling for Imperva.
Which institutional investors are buying Imperva stock?
IMPV stock was purchased by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Dimensional Fund Advisors LP, Emerald Mutual Fund Advisers Trust, Emerald Advisers Inc. PA, Credit Suisse AG, Pictet Asset Management Ltd., SG Americas Securities LLC and BlackRock Inc.. View Insider Buying and Selling for Imperva.
How do I buy shares of Imperva?
Shares of IMPV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Imperva's stock price today?
One share of IMPV stock can currently be purchased for approximately $55.82.
How big of a company is Imperva?
Imperva has a market capitalization of $1.97 billion and generates $321.72 million in revenue each year. The software maker earns $22.86 million in net income (profit) each year or ($0.28) on an earnings per share basis. Imperva employs 1,020 workers across the globe.
What is Imperva's official website?
How can I contact Imperva?
Imperva's mailing address is 3400 BRIDGE PARKWAY, REDWOOD SHORES CA, 94065. The software maker can be reached via phone at 650-345-9000 or via email at [email protected]
MarketBeat Community Rating for Imperva (NASDAQ IMPV)
MarketBeat's community ratings are surveys of what our community members think about Imperva and other stocks. Vote "Outperform" if you believe IMPV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMPV will underperform the S&P 500 over the long term. You may vote once every thirty days.
